EUVIMEDEUVIMED entdecken
Crossref

Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure

Elizabeth Potter, Quan Huynh, Kawa Haji, Chiew Wong, Hong Yang, Leah Wright, Thomas H Marwick

JACC: Heart Failure · 2024

DOI: 10.1016/j.jchf.2023.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Elizabeth Potter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vi…. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinical and echocardiographic features predict incident heart failure (HF), but the optimal strategy for combining them is unclear. OBJECTIVES: This study sought to define an effective means of using echocardiography in HF risk evaluation. METHODS: The same clinical and echocardiographic evaluation was obtained in 2 groups with HF risk factors: a training group (n = 926, followed to 7 years) and a validation group (n = 355, followed to 10 years). Clinical risk was categorized as low, intermediate, and high using 4-year ARIC (Atherosclerosis Risk In Communities) HF risk score cutpoints of 9% and 33%. A risk stratification algorithm based on clinical risk and echocardiographic markers of stage B HF (SBHF) (abnormal global longitudinal strain [GLS], diastolic dysfunction, or left ventricular hypertrophy) was developed using a classification and regression tree analysis and was validated. RESULTS: HF developed in 12% of the training group, including 9%, 18%, and 73% of low-, intermediate-, and high-risk patients. HF occurred in 8.6% of stage A HF and 19.4% of SBHF (P < 0.001), but stage A HF with clinical risk of ≥9% had similar outcome to SBHF. Abnormal GLS (HR: 2.92 [95% CI: 1.95-4.37]; P < 0.001) was the strongest independent predictor of HF. Normal GLS and diastolic function reclassified 61% of the intermediate-risk group into the low-risk group (HF incidence: 12%). In the validation group, 11% developed HF over 4.5 years; 4%, 17%, and 39% of low-, intermediate-, and high-risk groups. Similar results were obtained after exclusion of patients with known coronary artery disease. The echocardiographic parameters also provided significant incremental value to the ARIC score in predicting new HF admission (C-statistic: 0.78 [95% CI: 0.71-0.84] vs 0.83 [95% CI: 0.77-0.88]; P = 0.027). CONCLUSIONS: Clinical risk assessment is adequate to classify low and high HF risk. Echocardiographic evaluation reclassifies 61% of intermediate-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureVentricular Dysfunction, LeftHumansEchocardiographyRisk FactorsHypertrophy, Left VentricularRisk AssessmentVentricular Function, LeftStroke VolumePrognosis

Stichwörter der Autor:innen

echocardiographyglobal longitudinal strainheart failure

Autor:innen und Institutionen

  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Western Health, Melbourne, Victoria, Australia.
  • Northern Health, Melbourne, Victoria, Australia.
  • Menzies Institute for Medical Research, Hobart, Tasmania, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Western Health, Melbourne, Victoria, Australia; Men…

Zitieren

APA

Potter, E., Huynh, Q., Haji, K., Wong, C., Yang, H., Wright, L., & Marwick, T. H. (2024). Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.06.014

Vancouver

Potter E, Huynh Q, Haji K, Wong C, Yang H, Wright L, et al. Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2023.06.014

BibTeX
@article{Potter2024,
  author = {Potter, Elizabeth and Huynh, Quan and Haji, Kawa and Wong, Chiew and Yang, Hong and Wright, Leah and Marwick, Thomas H},
  title = {Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure},
  journal = {JACC: Heart Failure},
  year = {2024},
  doi = {10.1016/j.jchf.2023.06.014}
}
Kostenlos starten →